Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vita Blomman pharma AB
AB
Active
Org 5590994264
General medical practice activities
· NACE 8621
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Vita Blomman pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
26
17
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
10
16
−2
−2
−2
Depreciation & amort.
−0
—
—
—
—
EBIT
10
16
−2
−2
−2
Net financials
—
−0
−1
−0
0
Profit before tax
10
16
−2
−2
−2
Tax
−1
−3
—
—
—
Net profit
9
13
−2
−2
−2
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
578
732
585
445
404
Equity
544
557
555
418
376
Long-term debt
0
—
—
—
—
Short-term debt
33
175
30
27
27
Total debt
33
175
30
27
27
Financial ratios
5-year trend
EBITDA margin
-156000.0%
This company
15.8%
Market median
-987442% vs market
2021
2025
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
2021
2025
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
2021
2025
Net profit margin
-155900.0%
This company
8.1%
Market median
-1924791% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Vita Blomman pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot